Cumberland Pharmaceuticals (NASDAQ:CPIX) is a specialty pharmaceutical company primarily engaged in the acquisition, development, and commercialization of prescription products. The company focuses on delivering innovative treatments for underserved patient populations in areas such as gastroenterology, oncology, and acute care medicine. With a diverse portfolio that includes both marketed products and products in various stages of clinical development, Cumberland Pharmaceuticals aims to improve patient care and outcomes through its high-quality medications and therapeutic solutions. The company's objectives center around expanding its product lineup through strategic partnerships, advancing its pipeline of potential new therapies, and continuing to grow its presence in the healthcare market.